Omega Bio-Tek, Norcross, Ga, and Ipsum Diagnostics, Sandy Springs, Ga, are combining their resources in the fight against covid-19. Omega Bio-Tek will supply its Mag-Bind viral DNA/RNA 96 kit as a vital element in Ipsum Diagnostics’ RT-PCR-based SARS-CoV-2 assay.
On April 1, FDA granted emergency use authorization to Ipsum Diagnostics for its RT-PCR-based SARS-CoV-2 test, which includes the Mag-Bind viral DNA/RNA 96 kit for viral RNA extraction. The Georgia Department of Health also issued an agreement with Ipsum Diagnostics to expand its statewide testing utilizing the approved assay.

“Ipsum Diagnostics reached out to us with interest to purchase our kits on a Saturday, and we were able to process the order, provide robotic scripts, and offer pickup at our location that same day,” says Travis Butts, vice president of Omega Bio-Tek. Foreseeing the shortage of RNA extraction kits worldwide, Omega Bio-Tek had ramped up production of the Mag-Bind viral DNA/RNA 96 kit at the beginning of the pandemic.

For more information, visit Omega Bio-Tek and Ipsum Diagnostics.